Research Article
The Mosaic of “Seronegative” Antiphospholipid Syndrome
Table 1
Clinical characteristics of patients studied.
| Characteristics (%) | SN-APS () | APS () |
| Other autoimmune diseases | 17 (70.8) | 16 (64) | SLE | 9 (37.5) | 16 (64) | Sjögren syndrome secondary to SLE | 2 (8.3) | 8 (32) | Primary Sjögren syndrome | 1 (4.2) | 0 | Rhupus | 1 (4.2) | 0 | Mixed connective tissue disease | 1 (4.2) | 0 | Undifferentiated connective tissue | 1 (4.2) | 0 | Disease | 1 (4.2) | 0 | Urticarial vasculitis | 1 (4.2) | 0 | LED | 1 (4.2) | 0 | Myasthenia gravis | 0 | 1 (4) | None | 5 (20.8) | 9 (36) | Vascular thrombosis | 18 (75) | 24 (96) | Venous thrombosis | 10 (41.6) | 17 (68) | Arterial thrombosis | 12 (50) | 10 (40) | Recurrent thrombosis | 8 (33.3) | 10 (40) | Pregnancy morbidity | 8 (33.3) | 9 (36) | Normal fetus deaths | 7 (29.2) | 2 (8) | Premature births | 0 | 0 | Spontaneous abortions | 5 (20.8) | 8 (32) | Vascular thrombosis and pregnancy morbidity | 3 (12.5) | 6 (24) | Noncriteria APS features | | | Livedo reticularis | 5 (20.8) | 7 (28) | Thrombocytopenia | 1 (4.2) | 5 (20) | Cognitive dysfunctions | 1 (4.2) | 6 (24) | Migraine | 5 (20.8) | 8 (32) | Seizures | 0 | 5 (20) | Brain MRI scan abnormalities | 10 (41.6) | 8 (32) | Thrombotic risk factors | 15 (62.5) | 14 (56) | Hypercholesterolemia | 5 (20.8) | 10 (40) | Smoking | 12 (50) | 5 (20) | Hypertension | 6 (25) | 7 (28) | OC/HRT | 2 (8.3) | 2 (8) | Diabetes mellitus | 1 (4.2) | 0 |
|
|